The study was small, and experts say it needs to be replicated. But for 18 people with rectal cancer, the outcome led to “happy tears.”
A Cancer Trial’s Unexpected Result: Remission in Every Patient (Published 2022)
https://www.nytimes.com/2022/06/05/health/rectal-cancer-checkpoint-inhibitor.html
2 Comments
daitya@lemmy.world · 2 pts · 3y
This was published one year ago, and I wonder if there have been followup trials since.
racer983@mander.xyz · 2 pts · 3y
Looks like this drug has multiple on going trials. Here is a phase II/III trial ongoing that's probably the direct successor to the trial in the article. It's currently recruiting, they expect to be done some time in 2025.
https://classic.clinicaltrials.gov/ct2/show/NCT05723562
Clinicaltrials.gov makes it really easy to find pretty much any trial.